Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PPARy agonist for treatment of progressive supranuclear palsy

PPARy agonist for treatment of progressive supranuclear palsy

US Patent 11253508 · Granted Feb 22, 2022

Estimated economic value: $7,791,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cereblon modulators and uses thereof2023
Cereblon modulators and uses thereof2020
In vivo engineered cereblon protein2020
Methods for treating pulmonary fibrosis2020
Compositions and methods for treating alopecia2019
Compositions and methods for treating alopecia2019
PPARγ agonists for treatment of multiple sclerosis2018
PPAR gamma agonists for treatment of multiple sclerosis2017
PPAR gamma agonists for treatment of multiple sclerosis2015
Soluble tumor necrosis factor receptor treatment of medical disorders2014
Soluble tumor necrosis factor receptor treatment of medical disorders2013
Soluble tumor necrosis factor receptor treatment of medical disorders2012